🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Honored to receive such an acknowledgment & excited to share what I have learned about #plasticity in the Charlie Rudin lab at Memorial Sloan Kettering Cancer Center during the last 6 years! #LCSM. Also thanks to American Lung Association and EGFR Resisters for funding some of the work I will present.

Join us for this exciting event organized by National Cancer Center, Japan! Looking forward for insightful discussions on screening and management of early-stage lung cancer! Hidehito HORINOUCHI ATLAS project by National Cancer Center, Japan

the latest ModPath CHAT is here! Staging of Multiple NSCLC: Paradigm shift using molecular methods Natasha Rekhtman MD PhD USCAP Penn Medicine Penn Path & Lab Medicine Modern Pathology Selwyn M. Vickers Memorial Sloan Kettering Cancer Center MSK Department of Pathology & Laboratory Medicine podcasts.apple.com/us/podcast/sta…

Now online in Cancer Discovery: #Chromothripsis-mediated Small Cell Lung Carcinoma - by Natasha Rekhtman MD PhD Sam T Christopher Febres-Aldana, MD Charlie Rudin and colleagues doi.org/10.1158/2159-8… Memorial Sloan Kettering Cancer Center #SCLC

Was lucky to join this team! A rare subgroup of SCLC originates from carcinoids. Surprisingly, their genomic hallmark was whole-chromosomal chromothripsis amplifying oncogenes. Thanks and congrats to my mentors and the leads Charlie Rudin Natasha Rekhtman MD PhD Sam T Christopher Febres-Aldana, MD

A must-read landmark study by the brilliant Memorial Sloan Kettering Cancer Center team with Natasha Rekhtman MD PhD and Charlie Rudin at the helm. #Pulmpath #SCLC #Carcinoid

John Hopkins Pathology is recruiting for our 2026-2027 advanced surgical pathology fellowship. See below for more details.

Just posted on mskcc.org/news - incredibly moving story about the index patient in our recent study on chromothripsis-mediated small cell lung carcinoma. x.com/natasharekhtma… Khaliq Sanda was a 19 yo premed student when he received the diagnosis. Our entire team was

Thoracic Pathology Course co-hosted by MGH/MSKCC taking place this Friday to Sunday, Sept 13-15! The course is virtual, please join us! cmecatalog.hms.harvard.edu/thoracic-patho…

Starting in T-minus 12 hours! ⏲️

A team of doctors & researchers at MSK have identified a new, rare type of small cell #lungcancer that primarily affects younger people who have never smoked. Natasha Rekhtman MD PhD & Charlie Rudin published a paper in Cancer Discovery w/ their analysis. Learn more: bit.ly/3XqYKZG

Fantastic presentation on AI applications in #breastpathology by Fresia Pareja at the#ILCsymposium breast symposium in Leuven. MSK Department of Pathology & Laboratory Medicine Samson W. Fine, MD Hannah Wen ISBP Stuart Schnitt Anne Vincent-Salomon Christine Desmedt

patient can result from developmental somatic mosaicism in the adult lung. This occurs when only some normal cells in the body carry shared mutations, including a driver EGFR mutation. nature.com/articles/s4301… Congratulations to all co-authors on this study!

First report of response to tarlatamab in a patient with atypical carcinoid JTO & JTO CRR. Multiple prior lines of therapy - tumor had high DLL3 expression and mounted a response to this DLL3 BiTE. jtocrr.org/article/S2666-…

Send your applications!! This is a very well established program I have the honor to co-chair with Rami Manochakian MD, FASCO Cancer Education and with an amazing mentoring group! Anne Tsao, MD, MBA Marina Garassino Dr. Luis E. Raez Jyoti D Patel Balazs Halmos Alona Zer Dr. Amy C. Moore Triparna Sen (Sen-Lab) LudaBazhenovaMD and more!

Please join us tomorrow morning, November 13 at 11 am ET for the ISIMM Web monthly webinar. Soo-Ryum (Stew) Yang MD from MSK Department of Pathology & Laboratory Medicine is presenting "Predictive Immunohistochemical Biomarkers in NSCLC." Register here: us02web.zoom.us/webinar/regist… Share widely!

Imaging from a 30-year-old woman with hematuria reveals diffuse, thin-walled cysts. A wedge biopsy is shown. What is the most likely underlying mutation? A) TSC2 B) BRAF p.V600E C) FLCN #PulmPath #PathTwitter #pathology 🔬tumourclassification.iarc.who.int/Viewer/Index2?…

🚨New Publication Alert 🚨 🚫 Rare lung cancers have a paucity of info ➕ they aren’t in 1️⃣ place. ✅ Build a compendium to highlight clinical features, genomics, pathology, treatments, complimented by real world cases w/ IU Simon Comprehensive Cancer Center experience. 🔎 Find it Lung Cancer Journal

We have unexpected opening for a Pathology Fellowship in the Renal/Genitourinary field for the 2025-2026 academic year. Please follow the link for more information on requirements, stipends & where to apply. Yale School of Medicine bit.ly/3DiON9Z

🚨Fellowship Opening 2026-27: Bone & Soft Tissue Pathology #bstpath - Learn from experienced BST pathologists in large volume cancer ctr with >3000 BST cases/yr - Sign out complex BST cases, participate in tumor boards and research projects - Details & contact in link below